The Early Reversibility of Rocuronium After Different Doses of Neostigmine
Clinical trial NCT00001520 · COMPLETED
Trial details
- NCT number
- NCT00001520
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 1996-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.